Happy Holidays. Keep checking for new content.

Genetics

Genetic test for BRCA1/2

May 7, 2017

BRCA1 and BRCA2 are human genes that produce tumor suppressor proteins. Men with harmful BRCA1 or BRCA2 mutations have a higher risk of prostate cancer. A Toronto Women’s College Hospital research study, The Screen Project, provides Canadians access to affordable population-based genetic testing for the BRCA gene mutation. Watch the video here.

Read the article or watch the video →

Leading researchers recommend major change in prostate cancer treatment

April 9, 2017

Leading American and British cancer researchers are urging that all men with advanced prostate cancer strongly consider being tested for inherited gene mutations — both to help steer their treatment and to alert family members who themselves might be at increased risk for a range of cancers. Read the article here.

Read the article or watch the video →

New way to identify patients at risk for aggressive prostate cancer

April 9, 2017

Scientists at Cedars-Sinai Medical Center have developed a new way to identify which prostate cancer patients are likely to develop aggressive types of the disease even if their tumors at first appear to be lower risk. Read the article here.

Read the article or watch the video →

Salmonella could shrink prostate cancer cells

January 2, 2017

Scientists at Swansea University say they have made a breakthrough which could revolutionise prostate cancer treatment. Researchers at the university’s School of Medicine have developed a way of shrinking cancer cells using a harmless strain of salmonella bacteria. Read the article here.

Read the article or watch the video →

Revolutionary new cancer treatment makes patients SIX TIMES more likely to survive

September 13, 2016

A revolutionary new DNA treatment technique involves having a simple DNA test of your tumour first. This then tells doctors precisely which drugs or therapies are most suited to you – rather than relying on the standard treatment. The genetic profiling of your tumour can also tell doctors which drugs you should avoid because they […]

Read the article or watch the video →

Markers redefining prostate cancer care

July 3, 2016

The discovery of new prostate cancer biomarkers has led to a number of tests that have begun to alter the diagnosis and management of the disease. Read the article.

Read the article or watch the video →

Video: Justin Lorentz and Dr. Danny Vesprini, “Genetically Predisposed: Who is at Increased Risk of Developing Prostate Cancer?”

April 30, 2016

March 2016 Awareness Night Genetically Predisposed: Who is at Increased Risk of Developing Prostate Cancer? Justin Lorentz,  MSc, CGC Certified Genetic Counsellor, Male Oncology Research and Education (MORE) Lead, Dept of Radiation Oncology Sunnybrook Odette Cancer Centre   Dr. Danny Vesprini, MD, MSc, FRCPC Assistant Professor, U. of Toronto Dept of Radiation Oncology Affiliate Scientist, […]

Read the article or watch the video →

New Diagnostic Tools for Prostate Cancer

March 20, 2016

A new genomic test, Oncotype DX, gauges how lethal a tumor is by looking at the expression of 17 genes in the tumor. Read the article.

Read the article or watch the video →

Semen-based test for diagnosing prostate cancer could reduce unnecessary biopsies

March 6, 2016

Dr. Eleftherios Diamandis, a researcher at Toronto’s Mount Sinai Hospital, would like a better alternative that could reduce unnecessary biopsies. Dr. Diamandis plans to spend the next two years developing a non-invasive test that can help determine when high PSA levels warrant concern. To do this, he will zero in on genetic mutations found in […]

Read the article or watch the video →

Prostate cancer researchers develop personalized genetic test to predict recurrence risk

November 20, 2014

(TORONTO, Canada – Nov. 13, 2014) – Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy. Read the article.

Read the article or watch the video →